Lead sponsor
Axsome Therapeutics, Inc.
5 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
5
Trials led
0
Ongoing
1,547
Total enrollment
174
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 2/3
1
Phase 3
4
Trials by status
Completed
4
Terminated
1
Trials led
TrialEligibility highlightPhaseStatusEnrollment
An Open-Label Study to Assess the Long-term Safety of AXS-05 in Subjects With Dementia of the Alzheimer's Type, ADVANCE-2 and ACCORD-2 Extension StudyStudy partner/caregiver requiredPh 3Terminated139